Home/Filings/4/0001077183-21-000280
4//SEC Filing

Wallar Gina M 4

Accession 0001077183-21-000280

CIK 0001077183other

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 6:05 PM ET

Size

13.1 KB

Accession

0001077183-21-000280

Insider Transaction Report

Form 4
Period: 2021-12-30
Wallar Gina M
President, Pharma Services
Transactions
  • Award

    Common Stock

    2021-12-30+15,28621,299 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $9.22Exp: 2023-04-19Common Stock (6,667 underlying)
    6,667
  • Stock Option (Right to Buy)

    Exercise: $20.83Exp: 2026-05-01Common Stock (7,153 underlying)
    7,153
  • Stock Option (Right to Buy)

    Exercise: $48.99Exp: 2028-05-01Common Stock (8,595 underlying)
    8,595
  • Stock Option (Right to Buy)

    Exercise: $13.87Exp: 2023-12-12Common Stock (8,334 underlying)
    8,334
  • Stock Option (Right to Buy)

    Exercise: $27.34Exp: 2027-05-01Common Stock (7,879 underlying)
    7,879
  • Stock Option (Right to Buy)

    Exercise: $43.95Exp: 2028-07-05Common Stock (10,126 underlying)
    10,126
Footnotes (7)
  • [F1]On December 30, 2021, Ms. Wallar was granted 15,286 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
  • [F2]On April 19, 2018, Ms. Wallar was granted 20,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
  • [F3]On December 12, 2018, Ms. Wallar was granted 25,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
  • [F4]On May 1, 2019, Ms. Wallar was granted 9,537 stock options. The options vest ratably over the first four anniversary dates of the grant date.
  • [F5]On May 1, 2020, Ms. Wallar was granted 7,879 stock options. The options vest ratably over the first four anniversary dates of the grant date.
  • [F6]On May 1, 2021, Ms. Wallar was granted 8,595 stock options. The options vest ratably over the first four anniversary dates of the grant date.
  • [F7]On July 5, 2021, Ms. Wallar was granted 10,126 stock options. The options vest ratably over the first four anniversary dates of the grant date.

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1
  • filerCIK 0001869819

Filing Metadata

Form type
4
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 6:05 PM ET
Size
13.1 KB